Home TRANG CHỦ Thứ 6, ngày 16/11/2018
    Hỏi đáp   Diễn đàn   Sơ đồ site     Liên hệ     English
IMPE-QN
Web Sites & Commerce Giới thiệu
Web Sites & Commerce Tin tức - Sự kiện
Web Sites & Commerce Hoạt động hợp tác
Web Sites & Commerce Hoạt động đào tạo
Web Sites & Commerce Chuyên đề
Web Sites & Commerce Tư vấn sức khỏe
Web Sites & Commerce Tạp chí-Ấn phẩm
Finance & Retail Thư viện điện tử
Công trình nghiên cứu về Ký sinh trùng
Công trình nghiên cứu về Sốt rét & SXH
Công trình nghiên cứu về Côn trùng & véc tơ truyền
Đề tài NCKH đã nghiệm thu
Thông tin-Tư liệu NCKH
Web Sites & Commerce Hoạt động Đảng & Đoàn thể
Web Sites & Commerce Bạn trẻ
Web Sites & Commerce Văn bản pháp quy
Số liệu thống kê
Web Sites & Commerce An toàn thực phẩm & hóa chất
Web Sites & Commerce Thầy thuốc và Danh nhân
Web Sites & Commerce Ngành Y-Vinh dự và trách nhiệm
Web Sites & Commerce Trung tâm dịch vụ
Web Sites & Commerce Góc thư giản

Tìm kiếm

Đăng nhập
Tên truy cập
Mật khẩu

WEBLINKS
Website liên kết khác
 
 
Số lượt truy cập:
3 5 3 4 6 1 9 4
Số người đang truy cập
5 9
 Thư viện điện tử Công trình nghiên cứu về Sốt rét & SXH
Nghiên cứu áp dụng Ivermectin như một thuốc chống lan truyền trong giai đoan đoạn tiến tới loại trừ sốt rét

 

1.Dreyer G, Addiss D, Noroes J, Amaral F, Rocha A, Coutinho A. Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian filariasis. Trop Med Int Health. 1996;1:427–32.

2.Ismail MM, Weil GJ, Jayasinghe KS, Premaratne UN, Abeyewickreme W, Rajaratnam HN, et al. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. Trans R Soc Trop Med Hyg. 1996;90:684–8.

3.Ismail MM, Weil GJ, Jayasinghe KS, Premaratne UN, Abeyewickreme W, Rajaratnam HN, et al. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. Trans R Soc Trop Med Hyg. 1996;90:684–8.

4.Mendes AM, Albuquerque IS, Machado M, Pissarra J, Meireles P, Prudêncio M. Inhibition of Plasmodium Liver Infection by Ivermectin. Antimicrob Agents Chemother. 2017;61.

5.Okeibunor JC, Amuyunzu-Nyamongo M, o­nyeneho NG, Tchounkeu YFL, Manianga C, Kabali AT, et al. Where would I be without ivermectin? Capturing the benefits of community-directed treatment with ivermectin in Africa. Trop Med Int Health. 2011;16:608–21.

6.Chiu SH, Carlin JR, Taub R, Sestokas E, Zweig J, Vandenheuvel WJ, et al. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats. Drug Metab Dispos. 1988;16:728–36.

7.Zeng Z, Andrew NW, Arison BH, Luffer-Atlas D, Wang RW. Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica. 1998;28:313–21.

8.Kobylinski KC, Sylla M, Chapman PL, Sarr MD, Foy BD. Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. Am J Trop Med Hyg. 2011;85:3–5.

9.Alout H, Krajacich BJ, Meyers JI, Grubaugh ND, Brackney DE, Kobylinski KC, et al. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments. Malar J. 2014;13:417.


Hình 1

10.Sylla M, Kobylinski KC, Gray M, Chapman PL, Sarr MD, Rasgon JL, et al. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors. Malar J. 2010;9:365.

11.Seaman JA, Alout H, Meyers JI, Stenglein MD, Dabiré RK, Lozano-Fuentes S, et al. Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood meals. BMC Genomics. 2015;16:797.

12.Kobylinski KC, Ubalee R, Ponlawat A, Nitatsukprasert C, Phasomkulsolsil S, Wattanakul T, et al. Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles. Malar J. 2017;16:280.

13.Mahmood F, Walters LL, Guzman H, Tesh RB. Effect of ivermectin o­n the ovarian development of Aedes aegypti (Diptera: Culicidae). J Med Entomol. 1991;28:701–7.

14.Seaman JA, Alout H, Meyers JI, Stenglein MD, Dabiré RK, Lozano-Fuentes S, et al. Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood meals. BMC Genomics. 2015;16:797.

15.Guzzo CA, Furtek CI, Porras AG, Chen C, Tipping R, Clineschmidt CM, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol. 2002;42:1122–33.

16.Kobylinski KC, Escobedo-Vargas KS, López-Sifuentes VM, Durand S, Smith ES, Baldeviano GC, et al. Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi. Malar J. 2017;16:474.

17.Sampaio V de S, Rivas GB da S, Kobylinski K, Pinilla YT, Pimenta PFP, Lima JBP, et al. What does not kill it makes it weaker: effects of sub-lethal concentrations of ivermectin o­n the locomotor activity of Anopheles aquasalis. Parasit Vectors. 2017;10:623.

18.Ouédraogo AL, Bastiaens GJH, Tiono AB, Guelbéogo WM, Kobylinski KC, Ouédraogo A, et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis. 2015;60:357–65.

19.Chaccour CJ, Rabinovich NR, Slater H, Canavati SE, Bousema T, Lacerda M, et al. Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda. Malar J. 2015;14:243.

20.Sampaio VS, Beltrán TP, Kobylinski KC, Melo GC, Lima JBP, Silva SGM, et al. Filling gaps o­n ivermectin knowledge: effects o­n the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector. Malar J. 2016;15:491.

21.Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, et al. Ivermectin to reduce malaria transmission: A research agenda for a promising new tool for elimination. Malaria Journal. 2013;12:153.

22.Derua YA, Kisinza WN, Simonsen PE. Differential effect of human ivermectin treatment o­n blood feeding Anopheles gambiae and Culex quinquefasciatus. Parasit Vectors [Internet]. 2015 [cited 2015 Jun 5];8. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352294/

23.Chaccour C, Barrio ÁI, Royo AGG, Urbistondo DM, Slater H, Hammann F, et al. Screening for an ivermectin slow-release formulation suitable for malaria vector control. Malar J [Internet]. 2015 [cited 2015 Jun 5];14. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355127/

24.Alout H, Krajacich BJ, Meyers JI, Grubaugh ND, Brackney DE, Kobylinski KC, et al. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments. Malar J [Internet]. 2014 [cited 2015 Jun 5];13. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226880/

25.Ivermectin and malaria control.Ōmura S, Crump A.Malar J. 2017 Apr 24;16(1):172. doi: 10.1186/s12936-017-1825-9.PMID: 28438169 Free PMC Article Similar articles Select item 284381682.

26.Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria.Richards FO Jr.Malar J. 2017 Apr 24;16(1):168. doi: 10.1186/s12936-017-1830-z.PMID: 28438168 Free PMC Article Similar articles Select item 279605973.


Hình 2

27.Ivermectin: a complimentary weapon against the spread of malaria?Alout H, Foy BD.Expert Rev Anti Infect Ther. 2017 Mar;15(3):231-240. doi: 10.1080/14787210.2017.1271713. Epub 2016 Dec 29. Review.PMID: 27960597 Free PMC Article Similar articles Select item 217341164.

28.Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages.Kobylinski KC, Sylla M, Chapman PL, Sarr MD, Foy BD.Am J Trop Med Hyg. 2011 Jul;85(1):3-5. doi: 10.4269/ajtmh.2011.11-0160.PMID: 21734116 Free PMC Article Similar articles Select item 253633495.

29.Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments.Alout H, Krajacich BJ, Meyers JI, Grubaugh ND, Brackney DE, Kobylinski KC, Diclaro JW 2nd, Bolay FK, Fakoli LS, Diabaté A, Dabiré RK, Bougma RW, Foy BD.Malar J. 2014 Nov 3;13:417. doi: 10.1186/1475-2875-13-417.PMID: 25363349 Free PMC Article Similar articles Select item 111291306.

30.Drug treatment of tropical parasitic infections: recent achievements and developments.Stephenson I, Wiselka M.Drugs. 2000 Nov;60(5):985-95. Review.PMID: 11129130 Similar articles Select item 214110147.

31.Natural products as starting points for future anti-malarial therapies: going back to our roots?Wells TN.Malar J. 2011 Mar 15;10 Suppl 1:S3. doi: 10.1186/1475-2875-10-S1-S3. Review.PMID: 21411014 Free PMC Article Similar articles Select item 205409318.


Hình 3

32.The effect of oral anthelmintics o­n the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors.Kobylinski KC, Deus KM, Butters MP, Hongyu T, Gray M, da Silva IM, Sylla M, Foy BD.Acta Trop. 2010 Nov;116(2):119-26. doi: 10.1016/j.actatropica.2010.06.001. Epub 2010 Jun 9.PMID: 20540931 Free PMC Article Similar articles Select item 267085759.

33.Nobel prize for the artemisinin and ivermectin discoveries: a great boost towards elimination of the global infectious diseases of poverty.Tambo E, Khater EI, Chen JH, Bergquist R, Zhou XN.Infect Dis Poverty. 2015 Dec 28;4:58. doi: 10.1186/s40249-015-0091-8.PMID: 26708575 Free PMC Article Similar articles Select item 2618671510.

34.Human o­nchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme.Turner HC, Walker M, Lustigman S, Taylor DW, Basáñez MG.PLoS Negl Trop Dis. 2015 Jul 17;9(7):e0003938. doi: 10.1371/journal.pntd.0003938. eCollection 2015.PMID: 26186715 Free PMC Article Similar articles Select item 2132147811.

35.Ivermectin, 'wonder drug' from Japan: the human use perspective.Crump A, Ōmura S.Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(2):13-28. Review.PMID: 21321478 Free PMC Article Similar articles Select item 2494422812.

36.Reaching the london declaration o­n neglected tropical diseases goals for o­nchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum NK, Hopkins A, Prichard RK, Basáñez MG.Clin Infect Dis. 2014 Oct;59(7):923-32. doi: 10.1093/cid/ciu467. Epub 2014 Jun 18.PMID: 24944228 Free PMC Article Similar articles Select item 2665133513.

37.Administration of ivermectin to peridomestic cattle: a promising approach to target the residual transmission of human malaria.Pooda HS, Rayaisse JB, Hien DF, Lefèvre T, Yerbanga SR, Bengaly Z, Dabiré RK, Belem AM, Sidibé I, Solano P, Mouline K.Malar J. 2015 Dec 10;13 Suppl 1:496. doi: 10.1186/s12936-015-1001-z.PMID: 26651335 Free PMC Article Similar articles Select item 2513050714.

38.Ivermectin: panacea for resource-poor communities?Omura S, Crump A.Trends Parasitol. 2014 Sep;30(9):445-55. doi: 10.1016/j.pt.2014.07.005. Epub 2014 Aug 12. Review. PMID: 25130507 Similar articles Select item 2606856015.

39.Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.Chaccour CJ, Rabinovich NR, Slater H, Canavati SE, Bousema T, Lacerda M, Ter Kuile F, Drakeley C, Bassat Q, Foy BD, Kobylinski K.Malar J. 2015 Jun 11;14:243. doi: 10.1186/s12936-015-0691-6.PMID:26068560 Free PMC Article Similar articles Select item 2730156716.

40.Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for o­nchocerca volvulus in near elimination and surveillance settings.Bottomley C, Isham V, Vivas-Martínez S, Kuesel AC, Attah SK, Opoku NO, Lustigman S, Walker M, Basáñez MG.Parasit Vectors. 2016 Jun 14;9(1):343. doi: 10.1186/s13071-016-1605-3.PMID: 27301567 Free PMC Article Similar articles Select item 2216658017.

41.Neglected tropical diseases and the millennium development goals: why the "other diseases" matter: reality versus rhetoric.Molyneux DH, Malecela MN.Parasit Vectors. 2011 Dec 13;4:234. doi: 10.1186/1756-3305-4-234. Review.PMID: 22166580 Free PMC Article Similar articles Select item 2488674718.

42.Modelling the impact of ivermectin o­n River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.Turner HC, Walker M, Churcher TS, Basáñez MG.Parasit Vectors. 2014 May 26;7:241. doi: 10.1186/1756-3305-7-241.PMID: 24886747 Free PMC Article Similar articles Select item 2541426219.

43.Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.Ouédraogo AL, Bastiaens GJ, Tiono AB, Guelbéogo WM, Kobylinski KC, Ouédraogo A, Barry A, Bougouma EC, Nebie I, Ouattara MS, Lanke KH, Fleckenstein L, Sauerwein RW, Slater HC, Churcher TS, Sirima SB, Drakeley C, Bousema T.Clin Infect Dis. 2015 Feb 1;60(3):357-65. doi: 10.1093/cid/ciu797. Epub 2014 Nov 19. Erratum in: Clin Infect Dis. 2016 Sep 1;63(5):715. PMID: 25414262 Similar articles Select item 2364796920.


Hình 5

44.Ivermectin to reduce malaria transmission: A research agenda for a promising new tool for elimination. Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, Foy BD. Malar J. 2013 May 7;12:153. doi: 10.1186/1475-2875-12-153. PMID: 23647969 Free PMC Article Similar articles

45.Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors.Sylla M, Kobylinski KC, Gray M, Chapman PL, Sarr MD, Rasgon JL, Foy BD.Malar J. 2010 Dec 20;9:365. doi: 10.1186/1475-2875-9-365.PMID: 21171970 Free PMC Article Similar articles Select item 2645018622.

46.NOBEL PRIZES. Neglected tropical diseases get the limelight in Stockholm.Stokstad E, Vogel G. Science. 2015 Oct 9;350(6257):144-5. doi: 10.1126/science.350.6257.144. No abstract available. PMID: 26450186 Similar articles Select item 1724092123.

47.[Development of antituberculous drugs: current status and future prospects].Tomioka H, Namba K. Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese. PMID: 17240921 Similar articles Select item 2172702724.

48.Endectocides for malaria control.Foy BD, Kobylinski KC, da Silva IM, Rasgon JL, Sylla M.Trends Parasitol. 2011 Oct;27(10):423-8. doi: 10.1016/j.pt.2011.05.007. Epub 2011 Jul 3.PMID: 21727027 Free PMC Article Similar articles Select item 2073470825.


Hình 7

49.Community directed approach beyond ivermectin in Tanzania: a promising mechanism for the delivery of complex health interventions.Mutalemwa P, Kisinza WN, Kisoka WJ, Kilima S, Njau J, Tenu F, Nkya T, Magesa SM.Tanzan J Health Res. 2009 Jul;11(3):116-25.PMID: 20734708 Similar articles Select item 2507099826.

50.Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control.Kobylinski KC, Alout H, Foy BD, Clements A, Adisakwattana P, Swierczewski BE, Richardson JH.Am J Trop Med Hyg. 2014 Oct;91(4):655-62. doi: 10.4269/ajtmh.14-0187. Epub 2014 Jul 28.PMID: 25070998 Free PMC Article Similar articles Select item 2430435227.

51.Considerations o­n the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.Haynes RK, Cheu KW, N'Da D, Coghi P, Monti D.Infect Disord Drug Targets. 2013 Aug;13(4):217-77. Review.PMID: 24304352 Similar articles Select item 2785679628.


Hình 8

52.Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals.Bellinger AM, Jafari M, Grant TM, Zhang S, Slater HC, Wenger EA, Mo S, Lee YL, Mazdiyasni H, Kogan L, Barman R, Cleveland C, Booth L, Bensel T, Minahan D, Hurowitz HM, Tai T, Daily J, Nikolic B, Wood L, Eckhoff PA, Langer R, Traverso G.Sci Transl Med. 2016 Nov 16;8(365):365ra157.PMID: 27856796 Free PMC Article Similar articles Select item 2695736429.

53.Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.Stuckey EM, Miller JM, Littrell M, Chitnis N, Steketee R.Malar J. 2016 Mar 9;15:148. doi: 10.1186/s12936-016-1202-0.PMID:26957364 Free PMC Article Similar articles Select item 2748183430.

54.Antimalarial mass drug administration: ethical considerations.Cheah PY, White NJ.Int Health. 2016 Jul;8(4):235-8. doi: 10.1093/inthealth/ihw027. Epub 2016 Aug 1. Review.PMID: 27481834 Free PMC Article Similar articles Select item 2613011731.

55.A community-based cross-sectional study of the epidemiology of o­nchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.Dana D, Debalke S, Mekonnen Z, Kassahun W, Suleman S, Getahun K, Yewhalaw D.BMC Public Health. 2015 Jul 1;15:595. doi: 10.1186/s12889-015-1888-x.PMID: 26130117 Free PMC Article Similar articles Select item 2495182632.


Hình 9

56.The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study.Slater HC, Walker PG, Bousema T, Okell LC, Ghani AC.J Infect Dis. 2014 Dec 15;210(12):1972-80. doi: 10.1093/infdis/jiu351. Epub 2014 Jun 20.PMID: 24951826 Similar articles Select item 2587298633.

57.Screening for an ivermectin slow-release formulation suitable for malaria vector control. Chaccour C, Barrio Á, Gil Royo AG, Martinez Urbistondo D, Slater H, Hammann F, Del Pozo JL.Malar J. 2015 Mar 5;14:102. doi: 10.1186/s12936-015-0618-2.PMID: 25872986 Free PMC Article Similar articles Select item 2766014934.


Hình 10

58.Filling gaps o­n ivermectin knowledge: effects o­n the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector.Sampaio VS, Beltrán TP, Kobylinski KC, Melo GC, Lima JB, Silva SG, Rodriguez ÍC, Silveira H, Guerra MG, Bassat Q, Pimenta PF, Lacerda MV, Monteiro WM.Malar J. 2016 Sep 22;15(1):491.PMID: 27660149 Free PMC Article Similar articles Select item 1609894635.

59.Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!Mutabingwa TK.Acta Trop. 2005 Sep;95(3):305-15. Review.PMID: 16098946 Similar articles Select item 2149467436.

60.Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests.Thiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, Diallo I, Fall FB, Ndiaye JL, Albertini A, Lee E, Jorgensen P, Gaye O, Bell D.PLoS o­ne. 2011 Apr 6;6(4):e18419. doi: 10.1371/journal.pone.0018419.PMID: 21494674 Free PMC Article Similar articles Select item 2431883637.

61.Mass drug administration for malaria.Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Cochrane Database Syst Rev. 2013 Dec 9;(12):CD008846. doi: 10.1002/14651858.CD008846.pub2. Review. PMID: 24318836 Free PMC Article Similar articles Select item 1530569338.


Hình 12

62.[Combined antimalarial therapy using artemisinin].Majori G.Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian. PMID: 15305693 Similar articles Select item 2725119939.

63.Combating poor-quality anti-malarial medicines: a call to action.Bassat Q, Tanner M, Guerin PJ, Stricker K, Hamed K.Malar J. 2016 Jun 1;15:302. doi: 10.1186/s12936-016-1357-8. Review.PMID:27251199 Free PMC Article Similar articles Select item 2644095740.

64.[2015 Nobel Prize in Physiology or Medicine. Better health for millions of people thanks to drugs against parasites].Andersson J, Lendahl U, Forssberg H.Lakartidningen. 2015 Oct 6;112. pii: DRCD. Swedish. No abstract available. PMID: 26440957 Free Article Similar articles

65.Oral, Slow-Release Ivermectin: Biting Back at Malaria Vectors.Chaccour CJ, Rabinovich NR.Trends Parasitol. 2017 Mar;33(3):156-158. doi: 10.1016/j.pt.2016.12.008. Epub 2017 Jan 6.PMID: 28065670 Similar articles Select item 2372869342.

66.Home- or community-based programmes for treating malaria.Okwundu CI, Nagpal S, Musekiwa A, Sinclair D.Cochrane Database Syst Rev. 2013 May 31;(5):CD009527. doi: 10.1002/14651858.CD009527.pub2. Review.PMID: 23728693 Similar articles Select item 1949708343.


Hình 12

67.From malaria control to eradication: The WHO perspective.Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, Wernsdorfer WH.Trop Med Int Health. 2009 Jul;14(7):802-9. doi: 10.1111/j.1365-3156.2009.02287.x. Epub 2009 May 26.PMID: 19497083 Free Article Similar articles Select item 2367554944.

68.A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.Coulibaly YI, Dicko I, Keita M, Keita MM, Doumbia M, Daou A, Haidara FC, Sankare MH, Horton J, Whately-Smith C, Sow SO.PLoS Negl Trop Dis. 2013 May 9;7(5):e2221. doi: 10.1371/journal.pntd.0002221. Print 2013.PMID: 23675549 Free PMC Article Similar articles Select item 1766836645.

69.Malarial protease inhibitors: potential new chemotherapeutic agents.Sharma A.Curr Opin Investig Drugs. 2007 Aug;8(8):642-52. Review.PMID: 17668366 Similar articles Select item 976371846.

70.Interventions to improve the use of antimalarials in south-east Asia: an overview.Gomes M, Wayling S, Pang L.Bull World Health Organ. 1998;76 Suppl 1:9-19.PMID: 9763718 Free PMC Article Similar articles Select item 2308296047.


Hình 13

71.Malaria, anti malarial drugs and the role of melatonin.Srinivasan V, Mohamed M, Zakaria R, Ahmad AH. Infect Disord Drug Targets. 2012 Oct;12(5):371-9. Review.PMID: 23082960 Similar articles Select item 2601337148.

72.Review of mass drug administration for malaria and its operational challenges.Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, Shanks GD, Slutsker L, Kachur SP, Wegbreit J, Ippolito MM, Poirot E, Gosling R.Am J Trop Med Hyg. 2015 Jul;93(1):125-34. doi: 10.4269/ajtmh.14-0254. Epub 2015 May 26. Review.PMID: 26013371 Free PMC Article Similar articles Select item 2767769449.

73.The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border.Kajeechiwa L, Thwin MM, Shee PW, Yee NL, Elvina E, Peapah P, Kyawt K, Oo PT, PoWah W, Min JR, Wiladphaingern J, von Seidlein L, Nosten S, Nosten F.Malar J. 2016 Sep 27;15(1):494.PMID: 27677694 Free PMC Article Similar articles Select item 2449571550.

74.A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia.Dial NJ, Ceesay SJ, Gosling RD, D'Alessandro U, Baltzell KA.Malar J. 2014 Feb 4;13:47. doi: 10.1186/1475-2875-13-47.PMID: 24495715 Free PMC Article Similar articles Select item 2919067151.

75.malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication.malERA Refresh Consultative Panel o­n Insecticide and Drug Resistance.PLoS Med. 2017 Nov 30;14(11):e1002450. doi: 10.1371/journal.pmed.1002450. eCollection 2017 Nov. Review.PMID: 29190671 Free PMC Article Similar articles Select item 1871814752.


Hình 14

76.The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.Colatrella B. Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:7-11. doi: 10.1179/136485908X337418.PMID: 18718147 Similar articles Select item 2724544253.

77.Update o­n the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin.Wanji S, Tayong DB, Layland LE, Datchoua Poutcheu FR, Ndongmo WP, Kengne-Ouafo JA, Ritter M, Amvongo-Adjia N, Fombad FF, Njeshi CN, Nkwescheu AS, Enyong PA, Hoerauf A.Parasit Vectors. 2016 May 31;9(1):311. doi: 10.1186/s13071-016-1595-1.PMID:27245442 Free PMC Article Similar articles Select item 2789502254.


Hình 14

78.Inhibition of Plasmodium Liver Infection by Ivermectin.Mendes AM, Albuquerque IS, Machado M, Pissarra J, Meireles P, Prudêncio M.Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02005-16. doi: 10.1128/AAC.02005-16. Print 2017 Feb. PMID: 27895022 Free PMC Article Similar articles Select item 2816682655.

79.Socio-ecological dynamics and challenges to the governance of Neglected Tropical Disease control.Michael E, Madon S.Infect Dis Poverty. 2017 Feb 6;6(1):35. doi: 10.1186/s40249-016-0235-5. Review.PMID: 28166826 Free PMC Article Similar articles Select item 2213758556.

80.Assessment and monitoring of o­nchocerciasis in Latin America.Rodríguez-Pérez MA, Unnasch TR, Real-Najarro O.Adv Parasitol. 2011;77:175-226. doi: 10.1016/B978-0-12-391429-3.00008-3. Review.PMID: 22137585 Similar articles Select item 1940258557.


Hình 16

81.Community directed interventions for malaria, tuberculosis and vitamin A in o­nchocerciasis endemic districts of Tanzania.Kisinza WN, Kisoka WJ, Mutalemwa PP, Njau J, Tenu F, Nkya T, Kilima SP, Magesa SM.Tanzan J Health Res. 2008 Oct;10(4):232-9.PMID: 19402585 Similar articles Select item 2051560658.

82.When is enough enough? The need for a robust pipeline of high-quality antimalarials.Wells TN, Poll EM. Discov Med. 2010 May;9(48):389-98.PMID: 20515606 Free Article Similar articles Select item 1555094459.

83.The life and times of ivermectin - a success story.Omura S, Crump A.Nat Rev Microbiol. 2004 Dec;2(12):984-9. Review.PMID: 15550944 Similar articles Select item 2695455160.

84.Subsidising artemisinin-based combination therapy in the private retail sector.Opiyo N, Yamey G, Garner P. Cochrane Database Syst Rev. 2016 Mar 9;3:CD009926. doi: 10.1002/14651858.CD009926.pub2. Review. PMID: 26954551 Free PMC Article Similar articles

85.Anti-malarial market and policy surveys in sub-Saharan Africa.Diap G, Amuasi J, Boakye I, Sevcsik AM, Pecoul B.Malar J. 2010 Apr 23;9 Suppl 1:S1. doi: 10.1186/1475-2875-9-S1-S1.PMID: 20423536 Free PMC Article Similar articles Select item 1710254962.

86.Malaria: anti malarial resistance and policy ramifications and challenges.Kshirsagar NA.J Postgrad Med. 2006 Oct-Dec;52(4):291-3. Review.PMID: 17102549 Free Article Similar articles Select item 1920002563.

87.Drug resistance in Plasmodium: natural products in the fight against malaria.Turschner S, Efferth T.Mini Rev Med Chem. 2009 Feb;9(2):206-2124. Review.PMID: 19200025 Similar articles Select item 2634305964.

88.Antimalarial Drug: From its Development to Deface.Barik TK.Curr Drug Discov Technol. 2015;12(4):225-8. Review.PMID: 26343059 Similar articles Select item 2269231165.

89.Evaluation o­n implementation of the African programme for o­nchocerciasis control in Nigeria. Xie Z, Nsofor I, Tolhurst R. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Jun 18;44(3):403-6. Chinese. PMID: 22692311 Free Article Similar articles Select item 2147055566.

90.Public-private partnerships in neglected tropical disease control: the role of nongovernmental organisations.Bush S, Hopkins AD.Acta Trop. 2011 Sep;120 Suppl 1:S169-72. doi: 10.1016/j.actatropica.2011.01.011. Epub 2011 Apr 4.PMID: 21470555 Free Article Similar articles Select item 630876267.

91.Ivermectin: a potent new antiparasitic agent. Campbell WC, Fisher MH, Stapley EO, Albers-Schönberg G, Jacob TA. Science. 1983 Aug 26;221(4613):823-8. PMID: 6308762 Similar articles Select item 2013278868.

92.A community-directed strategy for sustainable malaria elimination o­n islands: short-term MDA integrated with ITNs and robust surveillance.Kaneko A.Acta Trop. 2010 Jun;114(3):177-83. doi: 10.1016/j.actatropica.2010.01.012. Epub 2010 Feb 2. Review.PMID: 20132788 Similar articles Select item 2009611169.

93.Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoé AD, Ubben D, Marrast AC, Gaye O.Malar J. 2010 Jan 22;9:30. doi: 10.1186/1475-2875-9-30.PMID: 20096111 Free PMC Article Similar articles Select item 2269475970.

94.Small molecule anti-malarial patents: a review (January 2010-June 2011).Svennas KL, Macdonald SJ, Willis PA.Expert Opin Ther Pat. 2012 Jun;22(6):607-43. doi: 10.1517/13543776.2012.691967. Review.PMID: 22694759 Similar articles Select item 1048415771.

95.Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact o­n mosquito survival.Bockarie MJ, Hii JL, Alexander ND, Bockarie F, Dagoro H, Kazura JW, Alpers MP.Med Vet Entomol. 1999 May;13(2):120-3. PMID: 10484157 Similar articles Select item 1057514172.


Hình 17

96.Iron chelators as anti-infectives; malaria as a paradigm.Cabantchik ZI, Moody-Haupt S, Gordeuk VR.FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):289-98. Review.PMID: 10575141 Free Article Similar articles Select item 2319949173.

97.Control and elimination of Plasmodium vivax.Shanks GD.Adv Parasitol. 2012;80:301-41. doi: 10.1016/B978-0-12-397900-1.00006-2.PMID: 23199491 Similar articles Select item 2218893374.

98.Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases.Hotez P.Vaccine. 2011 Dec 30;29 Suppl 4:D104-10. doi: 10.1016/j.vaccine.2011.06.024. Epub 2011 Dec 19. Review.PMID: 22188933 Similar articles Select item 2206629475.

99.Knowledge, attitudes and practices relating to malaria in a semi-urban area of Cameroon: choices and sources of antimalarials, self-treatment and resistance. Nsagha DS, Nsagha SM, Shey CU, Njunda AL, Kamga HL, Njamnshi AK. East Afr J Public Health. 2011 Jun;8(2):98-102. PMID: 22066294 Similar articles Select item 1962205676.

100.Prospects for the control of neglected tropical diseases by mass drug administration.Smits HL.Expert Rev Anti Infect Ther. 2009 Feb;7(1):37-56. doi: 10.1586/14787210.7.1.37. Review. PMID: 19622056 Similar articles Select item 2379313277.

101.Global trends in neglected tropical disease control and elimination: impact o­n child health. Barry MA, Simon GG, Mistry N, Hotez PJ. Arch Dis Child. 2013 Aug;98(8):635-41. doi: 10.1136/archdischild-2012-302338. Epub 2013 Jun 22. PMID: 23793132 Similar articles Select item 2808687478.

102.New developments in anti-malarial target candidate and product profiles. Burrows JN, Duparc S, Gutteridge WE, Hooft van Huijsduijnen R, Kaszubska W, Macintyre F, Mazzuri S, Möhrle JJ, Wells TNC. Malar J. 2017 Jan 13;16(1):26. doi: 10.1186/s12936-016-1675-x. Review. Erratum in: Malar J. 2017 Apr 18;16(1):151. PMID: 28086874 Free PMC Article Similar articles Select item 2482192079.

103.The contribution of mass drug administration to global health: past, present and future.Webster JP, Molyneux DH, Hotez PJ, Fenwick A.Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130434. doi: 10.1098/rstb.2013.0434. Print 2014. Review.PMID: 24821920 Free PMC Article Similar articles Select item 965373080.

104.Ecology, economics and political will: the vicissitudes of malaria strategies in Asia. Kidson C, Indaratna K. Parassitologia. 1998 Jun;40(1-2):39-46. PMID: 9653730 Similar articles

105.Honouring pioneers of treatments for malaria and nematode infections. Burki T. Lancet Infect Dis. 2015 Dec;15(12):1382. doi: 10.1016/S1473-3099(15)00418-1. Epub 2015 Nov 16. No abstract available. PMID: 26607125 Similar articles Select item 2097410582.

106.Mectizan(®) procurement and delivery for o­nchocerciasis mass drug administration programmes. Ogoussan KT, Hopkins A. Acta Trop. 2011 Sep;120 Suppl 1:S173-6. doi: 10.1016/j.actatropica.2010.10.004. Epub 2010 Oct 23. PMID: 20974105 Free Article Similar articles Select item 2432330883.

107.Larvivorous fish for preventing malaria transmission.Walshe DP, Garner P, Abdel-Hameed Adeel AA, Pyke GH, Burkot T.Cochrane Database Syst Rev. 2013 Dec 10;(12):CD008090. doi: 10.1002/14651858.CD008090.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Dec 11;12 :CD008090. PMID: 24323308 Free PMC Article Similar articles Select item 2816681384.

108.Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria.Abdul-Ghani R, Mahdy MA, Beier JC, Basco LK.Infect Dis Poverty. 2017 Feb 6;6(1):12. doi: 10.1186/s40249-016-0227-5. PMID: 28166813 Free PMC Article Similar articles Select item 1114801085.

109.Current status of malaria and potential for control.Phillips RS.Clin Microbiol Rev. 2001 Jan;14(1):208-26. Review.PMID: 11148010 Free PMC Article Similar articles Select item 2214505586.

110.Knowledge and practices relating to malaria in a semi-urban area of Cameroon: choices and sources of antimalarials, self-treatment and resistance.Nsagha DS, Njunda AL, Kamga HL, Nsagha SM, Nguedia Assob JC, Wiysonge CS, Tabah EN, Njamnshi AK.Pan Afr Med J. 2011;9:8. Epub 2011 May 25.PMID: 22145055 Free PMC Article Similar articles Select item 2430435587.

111.Discovering and developing new medicines for malaria control and elimination.Wells TN.Infect Disord Drug Targets. 2013 Aug;13(4):292-302.PMID: 24304355 Similar articles Select item 2704141088.

112.Progress Report o­n Neglected Tropical Disease Drug Donation Programs.Cohen JP, Silva L, Cohen A, Awatin J, Sturgeon R.Clin Ther. 2016 May;38(5):1193-204. doi: 10.1016/j.clinthera.2016.02.031. Epub 2016 Mar 31.PMID: 27041410 Similar articles Select item 1749327089.

113.Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions.Abuya TO, Mutemi W, Karisa B, Ochola SA, Fegan G, Marsh V.Malar J. 2007 May 10;6:57.PMID: 17493270 Free PMC Article Similar articles Select item 2780671790.

114.Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review.Adhikari B, James N, Newby G, von Seidlein L, White NJ, Day NP, Dondorp AM, Pell C, Cheah PY.Malar J. 2016 Nov 2;15(1):523. Review.PMID: 27806717 Free PMC Article Similar articles Select item 1721504591.

115.UK malaria treatment guidelines.Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA; HPA Advisory Committee o­n Malaria Prevention in UK Travellers.J Infect. 2007 Feb;54(2):111-21. Epub 2007 Jan 9.PMID: 17215045 Similar articles Select item 2978548492.

116.Challenges in Malaria Management and a Glimpse at Some Nanotechnological Approaches.Najer A, Palivan CG, Beck HP, Meier W.Adv Exp Med Biol. 2018;1052:103-112. doi: 10.1007/978-981-10-7572-8_9.PMID: 29785484 Similar articles Select item 3001625893.

117.High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug.Chosidow O, Bernigaud C, Do-Pham G.Parasite. 2018;25:33. doi: 10.1051/parasite/2018039. Epub 2018 Jul 16.PMID: 30016258 Free PMC Article Similar articles Select item 2960275394.

118.Ivermectin: repurposing an old drug to complement malaria vector control.Rabinovich NR.Lancet Infect Dis. 2018 Jun;18(6):584-585. doi: 10.1016/S1473-3099(18)30176-2. Epub 2018 Mar 27. No abstract available. PMID: 29602753 Similar articles Select item 2986511495.

119.Treatment of Malaria: The future armamentarium.Misra A.Natl Med J India. 1990 Mar-Apr;3(2):79. No abstract available. PMID: 29865114 Similar articles

 

Ngày 17/09/2018
TS.BS. Huỳnh Hồng Quang  

THÔNG BÁO

   Dịch vụ khám chữa bệnh chuyên khoa của Viện Sốt rét-KST-CT Quy Nhơn về các bệnh ký sinh trùng và các bệnh do véc tơ truyền, đặc biệt là các bệnh ký sinh trùng mới nổi như sán lá gan lớn, sán lá gan nhỏ, giun lươn, giun đũa chó và các bệnh thông thường khác; khám và xét nghiệm chẩn đoán bệnh bằng các phương tiện kỹ thuật cao như sinh hóa, huyết học, miễn dịch (ELISA), sinh học phân tử và chẩn đoán hình ảnh bằng nội soi tiêu hóa, siêu âm màu…

   Trung tâm Dịch vụ khoa học kỹ thuật của Viện Sốt rét-Ký sinh trùng-Côn trùng Quy Nhơn thuộc Bộ Y tế chuyên sản xuất mua bán hóa chất, vật tư, chế phẩm diệt côn trùng; dịch vụ diệt côn trùng gây bệnh, côn trùng gia dụng như muỗi, ruồi, gián, kiến…; dịch vụ phòng diệt mối mọt và xét nghiệm phát hiện tôm bằng các kỹ thuật hiện đại.


 LOẠI HÌNH DỊCH VỤ
 CHUYÊN ĐỀ
 PHẦN MỀM LIÊN KẾT
 CÁC VẤN ĐỀ QUAN TÂM
 QUẢNG CÁO

Trang tin điện tử Viện Sốt rét - Ký Sinh trùng - Côn trùng Quy Nhơn
Giấy phép thiết lập số 53/GP - BC do Bộ văn hóa thông tin cấp ngày 24/4/2005
Địa chỉ: Khu vực 8-Phường Nhơn Phú-Thành phố Quy Nhơn- Tỉnh Bình Định.
Tel: (84) 0256.3547492 - Fax: (84) 0256.3647464
Email: impe.quynhon@gmail.com
Trưởng ban biên tập: TTND.PGS.TS. Nguyễn Văn Chương - Viện trưởng
Phó Trưởng ban biên tập: TS.BS.Huỳnh Hồng Quang-Phó Viện trưởng
• Thiết kế bởi công ty cổ phần phần mềm: Quảng Ích